Several in vitro and in vivo results have expanded the role of these molecules from potentiating glucose-stimulated insulin secretion to promoting -cell survival under different stressful environments by favoring proliferation, neogenesis and resistance to apoptosis ( via secretion of IGF-2 from the same cells ( In agreement with experimental studies, GLP-1 analogues, particularly liraglutide, sustain the maintenance of -cell function in obese individuals with early T2D, and these effects are presumably independent of weight loss ( Further, experimental data suggest that the pro-survival action of GLP-1RAs may also be mediated by the Akt-dependent stimulation of the mTORC1/S6K1 pathway, the activation of which is dependent upon the IGF-1R, as observed in rodent islet cells ( in vitro , exendin-4 lost the ability to activate this pathway, suggesting that GLP-1 analogues may restore -cell proliferation via autocrine or paracrine activation of IGF-1R ( In concert, these results define a new scenario of action for incretin-based therapy that may involve the adipo-insular axis, linking the weight lowering competence with the sustained protection of -cells from diabetogenic stressors
In addition to mucosal protection, research has explored the peptides influence on gastrointestinal motility regulation
Specialized collections target gut health, longevity, and weight loss, enhancing your healthy lifestyle
Depending on individual evaluation, Kingdom providers may prescribe treatments that support appetite control, metabolic signaling, or fat utilization
You know, Im a libertarian at heart
A recent Cleveland Clinic study of nearly 8,000 patients found that many people who discontinue medications such as semaglutide or tirzepatide do not experience the significant weight regain often seen in clinical trials
